Dr. Shambayati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3300 NW 56th St
Suite 300
Oklahoma City, OK 73112Phone+1 405-768-3460
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Pediatric Gastroenterology, 2015 - 2018
- University of Texas Health Science Center at HoustonResidency, Pediatrics, 2012 - 2015
- Texas College of Osteopathic MedicineClass of 2012
Certifications & Licensure
- TX State License 2014 - 2026
- OK State License 2015 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
- AOA Board of Pediatrics Pediatrics
Clinical Trials
- A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children Start of enrollment: 2023 May 23
Roles: Principal Investigator
- A Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children Start of enrollment: 2023 Feb 20
Roles: Principal Investigator
Publications & Presentations
PubMed
- 8 citationsCentral inflammatory response to experimental stroke is inhibited by a neuroprotective dose of dietary soy.Maryam Shambayati, Maharshi Patel, Yulin Ma, Rebecca L. Cunningham, Derek A. Schreihofer
Brain Research. 2014-12-17
Press Mentions
- Maryam Shambayati, D.O.June 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: